Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T70977 | Target Info | |||
Target Name | Glycogen synthase kinase-3 beta (GSK-3B) | ||||
Synonyms | Serine/threonine-protein kinase GSK3B; GSK-3 beta | ||||
Target Type | Clinical trial Target | ||||
Gene Name | GSK3B | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Target Name | X-linked inhibitor of apoptosis protein (XIAP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | X-linked IAP; Xlinked IAP; RING-type E3 ubiquitin transferase XIAP; Inhibitor of apoptosis protein 3; ILP; IAP-like protein; IAPlike protein; IAP-3; IAP3; hILP; hIAP-3; hIAP3; E3 ubiquitin-protein ligase XIAP; E3 ubiquitinprotein ligase XIAP; BIRC4; Baculoviral IAP repeat-containing protein 4; Baculoviral IAP repeatcontaining protein 4; API3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Biochemical Activity | [2] | |||
Beta-transducin repeats | [+] 1 Beta-transducin repeats | + | |||
Interacting Target Name | UNR-interacting protein (STRAP) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WD-40 repeat protein PT-WD; UNRIP; UNR-interacting protein; MAWD; MAP activator with WD repeats | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [4] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Target Name | Serine/threonine PP1-alpha (PPP1CA) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein phosphatase PP1-alpha catalytic subunit; Protein phosphatase 1alpha; PPP1A; PP-1A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [6] | |||
Heat shock proteins | [+] 2 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Biochemical Activity | [8] | |||
Interacting Protein Name | Heat shock 70 kDa protein 4 (HSPA4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APG.2; HEL.S.5a; HS24/P52; HSPH2; RY; hsp70; hsp70RY | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [8] | |||
2 | Reconstituted Complex | [9] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Biochemical Activity | [11] | |||
3 | Reconstituted Complex | [12] | |||
Interacting Protein Name | cAMP-dependent protein kinase catalytic subunit alpha (PRKACA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PKACA; PKA C-alpha; cAMP-dependent protein kinase catalytic subunit alpha | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [13] | |||
2 | Affinity Capture-Western | [14] | |||
Microtubule-associated | [+] 1 Microtubule-associated | + | |||
Interacting Target Name | Microtubule-associated protein tau (MAPT) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | tau; TAU; Paired helical filament-tau; Paired helical filamenttau; Neurofibrillary tangle protein; MTBT1; Microtubule-associated protein tau; MAPTL | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Biochemical Activity | [16] | |||
3 | Biochemical Activity | [9] | |||
4 | Biochemical Activity | [17] | |||
5 | Biochemical Activity | [18] | |||
6 | Biochemical Activity | [19] | |||
7 | Biochemical Activity | [20] | |||
8 | Biochemical Activity | [21] | |||
9 | Biochemical Activity | [22] | |||
10 | Biochemical Activity | [23] | |||
11 | Biochemical Activity | [24] | |||
12 | Biochemical Activity | [25] | |||
13 | Reconstituted Complex | [9] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Protein Name | Ataxin-3 (ATXN3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AT3; ATX3; JOS; MJD; MJD1; SCA3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [26] | |||
2 | Biochemical Activity | [26] | |||
3 | Yeast two hybrid | [27] | |||
Pore-forming toxins | [+] 2 Pore-forming toxins | + | |||
Interacting Target Name | Amyloid beta A4 protein (APP) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Vascular beta-amyloid; Protease nexin-II; PreA4; PN-II; CVAP; Cerebral vascular amyloidpeptide; Cerebral vascular amyloid peptide; Beta-amyloid peptide; APPI; Amyloid-beta precursor protein; Amyloid-beta A4 protein; Amyloid precursor protein; Amyloid beta precursor protein; Alzheimer's disease amyloid protein; Alzheimer disease amyloid protein; AD1; ABPP; A4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Reconstituted Complex | [29] | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [25] | |||
2 | Yeast two hybrid | [27] | |||
Putative transporters | [+] 1 Putative transporters | + | |||
Interacting Target Name | LDL receptor related protein-6 (LRP-6) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Low-density lipoprotein receptor-related protein 6 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Far Western | [31] | |||
Transcription regulators | [+] 3 Transcription regulators | + | |||
Interacting Protein Name | Zinc finger protein SNAI1 (SNAI1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SLUGH2; SNA; SNAH; SNAIL; SNAIL1; dJ710H13.1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [32] | |||
2 | Affinity Capture-Western | [33] | |||
3 | Biochemical Activity | [32] | |||
Interacting Protein Name | Zinc finger protein SNAI2 (SNAI2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SLUG; SLUGH1; SNAIL2; WS2D | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Biochemical Activity | [35] | |||
3 | Biochemical Activity | [34] | |||
Interacting Target Name | Transcription factor AP-1 (JUN) | Discontinued Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | V-jun avian sarcoma virus 17 oncogene homolog; Transcription factor AP-1; Proto-oncogene c-jun; P39; C-jun proto-oncogene; AP-1 transcription factor; AP1; Activator protein-1; Activator protein 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [36] | |||
2 | Co-localization | [37] | |||
Other proteins | [+] 9 Other proteins | + | |||
Interacting Protein Name | Axin-1 (AXIN1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AXIN; PPP1R49 | ||||
Evidence Score (E-score) | 12 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [38] | |||
2 | Affinity Capture-MS | [13] | |||
3 | Affinity Capture-Western | [39] | |||
4 | Affinity Capture-Western | [40] | |||
5 | Affinity Capture-Western | [41] | |||
6 | Affinity Capture-Western | [28] | |||
7 | Affinity Capture-Western | [4] | |||
8 | Affinity Capture-Western | [42] | |||
9 | Affinity Capture-Western | [43] | |||
10 | Co-localization | [37] | |||
11 | Reconstituted Complex | [39] | |||
12 | Yeast two hybrid | [39] | |||
Interacting Target Name | Beta-catenin (CTNNB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Wnt/beta-catenin signaling pathway; PRO2286; OK/SW-cl.35; CTNNB; Catenin beta-1 | ||||
Evidence Score (E-score) | 11 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [13] | |||
2 | Affinity Capture-Western | [44] | |||
3 | Affinity Capture-Western | [40] | |||
4 | Biochemical Activity | [45] | |||
5 | Biochemical Activity | [46] | |||
6 | Biochemical Activity | [41] | |||
7 | Biochemical Activity | [47] | |||
8 | Biochemical Activity | [48] | |||
9 | Biochemical Activity | [49] | |||
10 | Biochemical Activity | [31] | |||
11 | Co-localization | [37] | |||
Interacting Target Name | MTOR complex 2 (RICTOR) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Rapamycin-insensitive companion of mTOR; KIAA1999; hAVO3; AVO3 homolog | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [47] | |||
2 | Biochemical Activity | [50] | |||
3 | Biochemical Activity | [47] | |||
Interacting Protein Name | A-kinase anchor protein 11 (AKAP11) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AKAP.11; AKAP220; PPP1R44; PRKA11 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [13] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Yeast two hybrid | [6] | |||
Interacting Protein Name | NF-kappa-B essential modulator (IKBKG) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AMCBX1; FIP.3; FIP3; Fip3p; IKK.gamma; IMD33; IP; IP1; IP2; IPD2; NEMO; ZC2HC9 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [51] | |||
2 | Biochemical Activity | [51] | |||
3 | Co-localization | [37] | |||
Interacting Target Name | Mucin-1 (MUC1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour-associated antigen mucin 1; Tumor-associated mucin; Tumor-associated epithelial membraneantigen; Tumor-associated epithelial membrane antigen; PUM; Polymorphic epithelial mucin; PEMT; PEM; Peanut-reactive urinary mucin; Mucin-1; MUC-1; Krebs von den Lungen-6; KL-6; H23AG; Episialin; EMA; CD227 antigen; CD227; Carcinoma-associated mucin; Cancer antigen 15-3; CA 15-3; Breast carcinoma-associated antigen DF3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Reconstituted Complex | [52] | |||
Interacting Protein Name | Adenomatous polyposis coli protein (APC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BTPS2; DP2; DP2.5; DP3; GS; PPP1R46 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [13] | |||
2 | Affinity Capture-Western | [53] | |||
Interacting Protein Name | F-box/WD repeat-containing protein 1A (BTRC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BETA.TRCP; FBW1A; FBXW1; FBXW1A; FWD1; bTrCP; bTrCP1; betaTrCP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
2 | Reconstituted Complex | [41] | |||
Interacting Protein Name | Tuberin (TSC2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LAM; PPP1R160; TSC4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [54] | |||
2 | Biochemical Activity | [55] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | XIAP associates with GSK3 and inhibits the promotion of intrinsic apoptotic signaling by GSK3. Cell Signal. 2009 Dec;21(12):1857-65. | ||||
REF 2 | Phosphorylation of XIAP at threonine 180 controls its activity in Wnt signaling. J Cell Sci. 2018 May 22;131(10). pii: jcs210575. | ||||
REF 3 | Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007;3:89. | ||||
REF 4 | Role of STRAP in regulating GSK3 function and Notch3 stabilization. Cell Cycle. 2011 May 15;10(10):1639-54. | ||||
REF 5 | Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators. Cell Rep. 2016 Nov 22;17(9):2488-2501. | ||||
REF 6 | A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3... J Biol Chem. 2002 Oct 4;277(40):36955-61. | ||||
REF 7 | Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3beta. Biochim Biophys Acta. 2009 Oct;1793(10):1597-603. | ||||
REF 8 | C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene. 2013 Jun 20;32(25):3101-10. | ||||
REF 9 | Stimulatory effect of -synuclein on the tau-phosphorylation by GSK-3. FEBS J. 2011 Dec;278(24):4895-904. | ||||
REF 10 | Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene. 2011 Jan 27;30(4):457-70. | ||||
REF 11 | Purification and characterization of recombinant CH3 domain fragment of the CREB-binding protein. Protein Expr Purif. 2010 Apr;70(2):196-205. | ||||
REF 12 | Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling. J Biol Chem. 2005 Sep 9;280(36):31924-35. | ||||
REF 13 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 14 | Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11960-5. | ||||
REF 15 | NUB1 modulation of GSK3 reduces tau aggregation. Hum Mol Genet. 2012 Dec 15;21(24):5254-67. | ||||
REF 16 | CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem. 2004 Feb 6;279(6):4869-76. | ||||
REF 17 | Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett. 1998 Sep 25;436(1):28-34. | ||||
REF 18 | Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry. 1999 Mar 23;38(12):3549-58. | ||||
REF 19 | Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem. 1998 Mar 15;252(3):542-52. | ||||
REF 20 | Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. FEBS Lett. 2007 Jun 12;581(14):2657-62. | ||||
REF 21 | Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett. 2002 Oct 23;530(1-3):209-14. | ||||
REF 22 | Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem. 2009 Jan;108(1):33-43. | ||||
REF 23 | Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. FEBS Lett. 2009 Jul 7;583(13):2194-200. | ||||
REF 24 | PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners. FEBS Lett. 2006 Nov 13;580(26):6269-74. | ||||
REF 25 | Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7951-5. | ||||
REF 26 | Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3. Biochem Biophys Res Commun. 2007 Jun 1;357(2):487-92. | ||||
REF 27 | A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011 Sep 6;4(189):rs8. | ||||
REF 28 | The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. Biochim Biophys Acta. 2012 Aug;1823(8):1233-41. | ||||
REF 29 | Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J Biol Chem. 2011 Sep 30;286(39):34088-100. | ||||
REF 30 | Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. Dev Cell. 2006 Aug;11(2):213-23. | ||||
REF 31 | Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling. PLoS One. 2008;3(12):e4046. | ||||
REF 32 | Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004 Oct;6(10):931-40. | ||||
REF 33 | Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell. 2009 May 5;15(5):416-28. | ||||
REF 34 | GSK3 controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug. Oncogene. 2014 Jun 12;33(24):3172-82. | ||||
REF 35 | Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16654-9. | ||||
REF 36 | PP2B-mediated dephosphorylation of c-Jun C terminus regulates phorbol ester-induced c-Jun/Sp1 interaction in A431 cells. Mol Biol Cell. 2007 Mar;18(3):1118-27. | ||||
REF 37 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 38 | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods. 2013 Apr;10(4):307-14. | ||||
REF 39 | Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells. 1998 Jun;3(6):395-403. | ||||
REF 40 | An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 1999 May 4;18(9):2401-10. | ||||
REF 41 | Induction of Gsk3--TrCP interaction is required for late phase stabilization of -catenin in canonical Wnt signaling. J Biol Chem. 2014 Mar 7;289(10):7099-108. | ||||
REF 42 | Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J Biol Chem. 2003 Apr 18;278(16):13995-4001. | ||||
REF 43 | The SIAH E3 ubiquitin ligases promote Wnt/-catenin signaling through mediating Wnt-induced Axin degradation. Genes Dev. 2017 May 1;31(9):904-915. | ||||
REF 44 | Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem. 2002;84(4):816-31. | ||||
REF 45 | DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol. 1999 Jun;19(6):4414-22. | ||||
REF 46 | The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol. 1999 Feb 25;9(4):207-10. | ||||
REF 47 | Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. J Biol Chem. 2015 May 29;290(22):14120-9. | ||||
REF 48 | APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase. Mol Cell. 2008 Dec 5;32(5):652-61. | ||||
REF 49 | Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell. 2005 Jul 22;19(2):159-70. | ||||
REF 50 | ER stress inhibits mTORC2 and Akt signaling through GSK-3-mediated phosphorylation of rictor. Sci Signal. 2011 Feb 22;4(161):ra10. | ||||
REF 51 | GSK-3 controls NF-kappaB activity via IKK/NEMO. Sci Rep. 2016 Dec 8;6:38553. | ||||
REF 52 | The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem. 2001 Mar 2;276(9):6061-4. | ||||
REF 53 | The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction p... Int J Oncol. 2001 Apr;18(4):843-7. | ||||
REF 54 | The tuberin-hamartin complex negatively regulates beta-catenin signaling activity. J Biol Chem. 2003 Feb 21;278(8):5947-51. | ||||
REF 55 | TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006 Sep 8;126(5):955-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.